Presentation about experimental Foot and Mouth vaccine production
Because the vaccine is synthetic, made up of tiny protein shells designed to trigger optimum immune response, it doesn’t rely on growing live infectious virus and is therefore much safer to produce. These empty viral shells have been engineered to be more stable; making the vaccine much easier to store and reducing the need for cold storage. This is important research because it represents a big step forward in the global campaign to control FMDV in countries where the disease is endemic, and could significantly reduce the threat to countries currently free of the disease. Crucially, this new approach to making and stabilising vaccine could also impact on how viruses from the same family are fought, including polio.
Last edited: 12 January 2022 11:30